Depuy Orthopedics, a division of Johnson and Johnson, has issued a WORLDWIDE RECALL of it's "metal-on-metal" ASR XL Acetabular System for Total Hip Replacement. This recall came after a determination that the these Hip Implants fail at an alarming rate. These "metal-on-metal" hip implants can shed particles into the patient causing serious, painful reactions, often leading to further surgery.
Depuy has released the following statement to the public:
"Data recently received by the company shows that more people than expected who received the ASR Hip System experienced pain and other symptoms that led to a second hip replacement surgery, called a revision surgery. For this reason, DePuy Orthopaedics is voluntarily recalling its ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System. This recall means additional testing and treatment may be necessary to ensure the hip is functioning well. In some cases, patients may need additional surgery."
Highly touted as one of the more successful and life-altering surgical procedures developed, the hip replacement surgery has allowed patients to regain mobility and most importantly, their lives back. Most patients who are candidates to receive a hip transplant suffer from chronic conditions such as osteonecrosis, hip disorders, osteoarthritis and rheumatoid arthritis, so the procedure can bring great relief. But even though the procedure is rooted in a tremendous amount of success for many, it can still be routed in some complications and defective systems.
If you’ve had a hip replacement, you should be aware that DePuy Orthopedics, a division of Johnson & Johnson, has recalled two very popular hip transplants. The Depuy Hip Recall was issued for the ASR Hip Resurfacing and the ASR XL Acetabular System, because of their potential side-effects, failure rates and a variety of complications.
Research shows these hip implants have significantly higher failure rates than other models and have caused serious problems for many. Such complications include loose cups, pseudo-tumors and allergic reactions to metal debris released by the implants. These problems commonly cause pain, swelling and difficulty walking, among other symptoms. Patients have also had persistent hip pain, cognitive decline and shortness of breath as the microscopic metallic particles from the hip implant were released into the bloodstream and tissues.
Many patients have since required a second hip replacement surgery due to the issues associated with the hip devices, and hundreds of lawsuits have been filed against DePuy following the onset of serious side effects. Additionally, the DePuy ASR devices are associated “metallosis,” a serious condition that can bring by rashes and nerve damage. This can occur when the metal-on-metal movement of the implant causes friction and releases dangerous levels of chromium and cobalt ions into the body.
In an editorial that ran in the June issue of The Journal of Arthroplasty, three leading physicians argued that metal hip implants “do not show any clinical advantage,” but rather “are producing a new series of complications.” Five years after receiving the DePuy implants, complications required 12 to 13 percent of patients to undergo a second hip replacement surgery. More than 13,000 individuals have received the DePuy ASR metal-on-metal hip replacement since it first became available in July of 2003.
Many personal injury attorneys are advertising for DePuy hip cases. Most of these firms refer to their “Mass Tort Divisions” to attract potential clients. At Coxwell & Associates, we ARE the Mass Tort Division. When you call to talk with an attorney, you will get one of us. Try doing that with some of these larger firms. We provide one on one personal contact with the client. Remember, to you it’s not a “class action” or “mass tort”. It’s your individual case. That’s the way we treat you.